For the quarter ending 2025-09-30, LMAT made $61,046,000 in revenue. $17,362,000 in net income. Net profit margin of 28.44%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net sales | 61,046,000 | 64,232,000 | 59,871,000 | 54,597,500 |
| Cost of sales | 15,091,000 | 19,258,000 | 18,451,000 | 16,970,000 |
| Gross profit | 45,955,000 | 44,974,000 | 41,420,000 | 37,627,500 |
| Sales and marketing | 11,923,000 | 14,895,000 | 14,212,000 | 12,156,000 |
| General and administrative | 10,750,000 | 10,396,000 | 10,487,000 | 9,252,500 |
| Research and development | 2,970,000 | 3,541,000 | 4,095,000 | 3,855,000 |
| Total operating expenses | 25,643,000 | 28,832,000 | 28,794,000 | 25,263,500 |
| Income from operations | 20,312,000 | 16,142,000 | 12,626,000 | 12,364,000 |
| Interest income | 3,864,000 | 2,980,000 | 2,903,000 | 1,305,500 |
| Interest expense | 1,297,000 | 1,299,000 | 1,290,000 | 51,250 |
| Other income (loss), net | -306,000 | 247,000 | 2,000 | -31,250 |
| Income before income taxes | 22,573,000 | 18,070,000 | 14,241,000 | 13,409,000 |
| Provision for income taxes | 5,211,000 | 4,291,000 | 3,230,000 | 2,873,500 |
| Net income | 17,362,000 | 13,779,000 | 11,011,000 | 10,535,500 |
| Basic (in dollars per share) | 0.77 | 0.61 | 0.49 | 0.465 |
| Basic (in shares) | 22,660,000 | 22,614,000 | 22,570,000 | -11,241,000 |
| Diluted (in dollars per share) | 0.75 | 0.6 | 0.48 | 0.46 |
| Diluted (in shares) | 24,392,000 | 22,892,000 | 22,899,000 | -11,391,000 |
LEMAITRE VASCULAR INC (LMAT)
LEMAITRE VASCULAR INC (LMAT)